(Q41582116)

English

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.

scientific article published on 29 May 2017

Statements

Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors. (English)
Matthias Kolberg
Jarle Bruun
Astrid Murumägi
Christian H Bergsland
Maren Høland
Ina A Eilertsen
Stine A Danielsen
29 May 2017
1156-1171

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit